Exsure is building exosome infrastructure for precision therapeutics.

We are developing next-generation drug delivery platforms designed to target cancer stem cells — the root drivers of tumor relapse and resistance. By combining exosome engineering with targeted delivery, our approach aims to improve therapeutic precision while reducing systemic toxicity.

Our work focuses on enabling a new paradigm in oncology: treating not just tumors, but the underlying biology that causes recurrence.

In parallel, we are building foundational infrastructure for the exosome ecosystem, including:
• Research-grade reagents
• Purified exosomes
• Scalable delivery platforms

We aim to accelerate the development of exosome-based therapeutics in India and globally.

EXSURE

Org chart

Teams

Offices